Last reviewed · How we verify

NCT06074068: F4C

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Recruiting now NA Last updated 15 April 2026
What this trial tests

NA trial testing Fathers for Change in Intimate Partner Violence in 1,080 participants. Currently enrolling.

Timeline
11 January 2024
Primary endpoint
31 August 2028
31 December 2028

Quick facts

Lead sponsorYale University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1,080
Start date11 January 2024
Primary completion31 August 2028
Estimated completion31 December 2028
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Yale University

Who can join

18 and older, any sex, with Intimate Partner Violence or Child Maltreatment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. In-Session Predictors of Treatment Outcome for Intimate Partner Violence: An Examination of Fathers for Change and Treatment as Usual.
    Shayani DR, Hayes AM, Grasso DJ, Stover CS. · · 2026 · PMID 41816253 · DOI 10.1037/trm0000651

Verify or expand the search:

Other recruiting trials for Intimate Partner Violence

Currently open trials in the same condition.

Other Yale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06074068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing